X0306
4
2019-11-04
true
0001720725
Oyster Point Pharma, Inc.
OYST
0001472698
KKR Fund Holdings L.P.
C/O KOHLBERG KRAVIS ROBERTS & CO. L.P.
9 WEST 57TH STREET, SUITE 4200
NEW YORK
NY
10019
true
0001081714
KRAVIS HENRY R
C/O KOHLBERG KRAVIS ROBERTS & CO. L.P.
9 WEST 57TH STREET, SUITE 4200
NEW YORK
NY
10019
true
0001081715
ROBERTS GEORGE R
C/O KOHLBERG KRAVIS ROBERTS & CO. L.P.
2800 SAND HILL ROAD, SUITE 200
MENLO PARK
CA
94025
true
0001472694
KKR Management LLC
C/O KOHLBERG KRAVIS ROBERTS & CO. L.P.
9 WEST 57TH STREET, SUITE 4200
NEW YORK
NY
10019
true
0001404912
KKR & Co. Inc.
C/O KOHLBERG KRAVIS ROBERTS & CO. L.P.
9 WEST 57TH STREET, SUITE 4200
NEW YORK
NY
10019
true
0001743754
KKR Group Holdings Corp.
C/O KOHLBERG KRAVIS ROBERTS & CO. L.P.
9 WEST 57TH STREET, SUITE 4200
NEW YORK
NY
10019
true
0001472697
KKR Fund Holdings GP Ltd
C/O KOHLBERG KRAVIS ROBERTS & CO. L.P.
9 WEST 57TH STREET, SUITE 4200
NEW YORK
NY
10019
true
Common Stock, par value $0.001 per share
2019-11-04
4
C
0
884622
A
884622
I
See footnotes
Common Stock, par value $0.001 per share
2019-11-04
4
P
0
155000
16
A
1039622
I
See footnotes
Series B Convertible Preferred Stock
2019-11-04
4
C
0
884622
D
Common Stock, par value $0.001 per share
884622
0
I
See footnotes
These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock, on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering.
The securities reported herein are held by Falcon Vision LLC. KKR Health Care Strategic Growth Fund L.P., as the managing member of Falcon Vision LLC, KKR Associates HCSG L.P., as the general partner of KKR Health Care Strategic Growth Fund L.P., KKR HCSG GP LLC, as the general partner of KKR Associates HCSG L.P., KKR Fund Holdings L.P., as the sole member of KKR HCSG GP LLC, KKR Fund Holdings GP Limited, as a general partner of KKR Fund Holdings L.P., KKR Group Holdings Corp., as a general partner of KKR Fund Holdings L.P. and the sole shareholder of KKR Fund Holdings GP Limited, KKR & Co. Inc., as the sole shareholder of KKR Group Holdings Corp., KKR Management LLC, as the Class B common stockholder of KKR & Co. Inc., and Messrs. Henry R. Kravis and George R. Roberts, as the designated members of KKR Management LLC, may be deemed to be the beneficial owners having shared voting and investment power with respect to the shares described in this footnote.
Each of Messrs. Kravis and Roberts disclaims beneficial ownership of the shares held by Falcon Vision LLC.
Due to the limitations of the Securities and Exchange Commission's electronic filing system, Falcon Vision LLC, KKR Health Care Strategic Growth Fund L.P., KKR Associates HCSG L.P. and KKR HCSG GP LLC have filed a separate Form 4 relating to the securities reported herein.
KKR FUND HOLDINGS L.P. By: KKR Fund Holdings GP Limited, its general partner By: /s/ Terence Gallagher, Attorney-in-fact for William J. Janetschek, Director
2019-11-04
HENRY R. KRAVIS By: /s/ Terence Gallagher, Attorney-in-fact
2019-11-04
GEORGE R. ROBERTS By: /s/ Terence Gallagher, Attorney-in-fact
2019-11-04
KKR MANAGEMENT LLC By: /s/ Terence Gallagher, Attorney-in-fact for William J. Janetschek, Chief Financial Officer
2019-11-04
KKR & CO. INC. By: /s/ Terence Gallagher, Attorney-in-fact for William J. Janetschek, Chief Financial Officer
2019-11-04
KKR GROUP HOLDINGS CORP. By: /s/ Terence Gallagher, Attorney-in-fact for William J. Janetschek, Chief Financial Officer
2019-11-04
KKR FUND HOLDINGS GP LIMITED By: /s/ Terence Gallagher, Attorney-in-fact for William J. Janetschek, Director
2019-11-04